The German pharmaceutical and agrochemical group Bayer announced today the purchase of the American company Asklepios BioPharmaceutical, specialized in cell and gene therapies, with the aim of strengthening its presence in this sector.
According to the statement issued by the company, Bayer will…
Read More...
